This subset of tme-lncRNAs was correlated with a previously published tumor-intrinsic transcriptomic signature of RB1 loss, suggesting that proliferative pathways in cancer cells may lead to concomitant changes in the immune microenvironment15. Here, RB1 is linked to neoplasm.